CSIMarket
 




Halozyme Therapeutics Inc   (NASDAQ: HALO)
Other Ticker:  
 
 




HALO Price to Book Ratio (Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Book Value Trailing 12 Months III. Quarter II. Quarter I. Quarter IV. Quarter III. Quarter
Price to Book (TTM) Ratio current            17.00            20.89            15.79            18.41            16.37
Book Value Y / Y Change 11.31 % 14.97 % 171.23 % 334.11 % 81.68 %
Stock performance to date 18.65 % -0.1 % 9.13 % -0.89 % -8.14 %

Price to Book ratio Comment
Despite shareprice increase of 18.65 %, from beginning of III. Quarter Halozyme Therapeutics Inc 's current Price to Book ratio has contracted due to Book Value growth of 11.31 %, to Price to Book ratio of 17.00, from average Price to Book ratio in the II. Quarter of 20.89.


What is Price to Book Ratio?
Valuation in Biotechnology & Pharmaceuticals Industry

Price to Book ratio Company Ranking
Within: No.
Industry #2
Sector #28
S&P 500 #462




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.